590 A. D ́avalos and M. A. Lasunci ́on
Simonetti, P., Gardana, C., & Pietta, P. (2001). Plasma levels of caffeic acid and antioxidant status
after red wine intake.J. Agric. Food Chem., 49, 5964–5968.
Sohal, R. S., & Weindruch, R. (1996). Oxidative stress, caloric restriction, and aging.Science, 273,
59–63.
Sorescu, D., Weiss, D., Lassegue, B., Clempus, R. E., Szocs, K., Sorescu, G. P., Valppu, L., Quinn,
M. T., Lambeth, J. D., Vega, J. D., Taylor, W. R., & Griendling, K. K. (2002). Superoxide
production and expression of nox family proteins in human atherosclerosis.Circulation, 105,
1429–1435.
St Leger, A. S., Cochrane, A. L., & Moore, F. (1979). Factors associatedwith cardiac mortality
in developed countries with particular reference to the consumption of wine.The Lancet, 1,
1017–1020.
Stein, J. H., Keevil, J. G., Wiebe, D. A., Aeschlimann, S., & Folts, J. D. (1999). Purple grape juice
improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in
patients with coronary artery disease.Circulation, 100, 1050–1055.
Stoclet, J. C., Chataigneau, T., Ndiaye, M., Oak, M. H., El Bedoui, J., & Chataigneau, M., (2004).
Schini-Kerth, V. B. Vascular protection by dietary polyphenols.Eur. J. Pharmacol., 500,
299–313.
Su, H. C., Hung, L. M., & Chen, J. K. (2006). Resveratrol, a red wine antioxidant, possesses an
insulin-like effect in streptozotocin-induced diabetic rats.Am. J. Physiol. Endocrinol. Metab.,
290 , E1339–E1346.
Takechi, R., Hiramatsu, N., Mamo, J. C., & Pal, S. (2004). Red wine polyphenolics suppress the
secretion and the synthesis of Apo B48 from human intestinal CaCo-2 cells.Biofactors, 22,
181–183.
Terra, X., Valls, J., Vitrac, X., Merrillon, J. M., Arola, L., Ardevol, A., Blade, C., Fernandez-Larrea,
J., Pujadas, G., Salvado, J., & Blay, M. (2007). Grape-seed procyanidins act as antiinflamma-
tory agents in endotoxin-stimulated RAW264.7 macrophages by inhibiting NFkB signaling
pathway.J. Agric. Food Chem., 55, 4357–4365.
Tissenbaum, H. A., & Guarente, L. (2001). Increased dosage of a sir-2 gene extends lifespan in
Caenorhabditis elegans.Nature, 410, 227–230.
Tontonoz, P., & Mangelsdorf, D. J. (2003). Liver X receptor signaling pathways in cardiovascular
disease.Mol. Endocrinol., 17, 985–993.
Ukil, A., Maity, S., & Das, P. K. (2006). Protection from experimental colitis by theaflavin-3,3’-
digallate correlates with inhibition of IKK and NF-kappaB activation.Br. J. Pharmacol., 149,
121–131.
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T., Mazur, M., & Telser, J. (2007). Free radicals
and antioxidants in normal physiological functions and human disease.Int. J. Biochem. Cell
Biol., 39, 44–84.
Vayalil, P. K., Mittal, A., & Katiyar, S. K. (2004). Proanthocyanidins from grapeseeds inhibit
expression of matrix metalloproteinases in human prostate carcinoma cells, which is asso-
ciated with the inhibition of activation of MAPK and NF kappa B.Carcinogenesis, 25,
987–995.
Vaziri, H., Dessain, S. K., Ng Eaton, E., Imai, S. I., Frye, R. A., Pandita, T. K., Guarente, L., &
Weinberg, R. A. (2001). hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase.Cell,
107 , 149–159.
Vidal, R., Hernandez-Vallejo, S., Pauquai, T., Texier, O., Rousset, M., Chambaz, J., Demignot, S.,
& Lacorte, J. M. (2005). Apple procyanidins decrease cholesterol esterification and lipoprotein
secretion in Caco-2/TC7 enterocytes.J. Lipid Res., 46, 258–268.
Vita, J. A. (2005). Polyphenols and cardiovascular disease: effects on endothelial and platelet func-
tion.Am.J.Clin.Nutr.,81, 292S–297S.
Vitaglione, P., Sforza, S., Galaverna, G., Ghidini, C., Caporaso, N., Vescovi, P. P., Fogliano, V., &
Marchelli, R. (2005). Bioavailability of trans-resveratrol from red wine in humans.Mol. Nutr.
Food Res., 49, 495–504.